The U.S. Department of Defense Alcohol and Substance Abuse Research Program (ASARP) has placed a research highlight on the Congressionally Directed Medical Research Programs (CDMRP) website describing the Institute of Translational Neuroscience (ITN), which is overseen by Dr. Jennifer Mitchell, and also includes descriptions of ongoing research by Dr. Andrew Kayser. The research highlights can be found here.
In an interview with The Atlantic, Dr. Stephen Hauser discussed the goals of the BRAIN Initiative, the future of ethical neuroscience, and a recent report from the Presidential Commission for the Study of Bioethical Issues regarding cognitive enhancement, consent, and the use of neuroscience in the legal system.
Dr. Caroline Tanner, Director of our Parkinson’s Disease Research, Education and Clinical Center (PADRECC), has been selected as a White House Champion of Change for Parkinson’s disease. With the Champions of Change program, the White House recognizes Americans who are making positive changes in their communities. Dr. Tanner will be honored at the White House and will be featured in a blog post on the White House website. The CDMRP website has profiled her as well.
Jeanne Paz, PhD, Assistant Professor of Neurology and an assistant investigator at the UC San Francisco-affiliated Gladstone Institutes, has been awarded the prestigious Michael Prize in recognition of her significant contributions to the field of epilepsy.
Louis Ptáček has received the prestigious Stanley J. Korsmeyer Award from the American Society for Clinical Investigation, in recognition of his research leading to the development of the field of ion channel defects, commonly known as channelopathies.
UC President Janet Napolitano has approved the appointment of Dan Lowenstein, MD, as the next Executive Vice-Chancellor and Provost.at UCSF. Dr. Lowenstein will collaborate with Chancellor Hawgood and other leaders to develop and implement campus priorities across our mission areas of research, education, and patient care. He will remain an integral part of the Department of Neurology and the Epilepsy Division, and Dr. Paul Garcia has agreed to serve as Interim Division Chief of Epilepsy during the transition.